BRCA in breast cancer: ESMO Clinical Practice Guidelines

被引：170

作者：

Balmana, J. ^{[1
]}

Diez, O. ^{[2
,3
]}

Rubio, I. T. ^{[4
]}

Cardoso, F. ^{[5
,6
]}

机构：

[1] Univ Hosp Vall dHebron, Breast Canc Ctr, Dept Med Oncol, Barcelona, Spain

[2] Univ Hosp Vall dHebron, Oncogenet Lab, Barcelona, Spain

[3] VHIO, Barcelona, Spain

[4] Univ Hosp Vall dHebron, Breast Canc Ctr, Breast Canc Surg Unit, Barcelona, Spain

[5] European Sch Oncol, Milan, Italy

[6] Champalimaud Canc Ctr, Breast Canc Unit, Lisbon, Portugal

[7] ESMO Head Off, CH-6962 Viganello Lugano, Switzerland

来源：

ANNALS OF ONCOLOGY | 2011年 / 22卷

关键词：

BILATERAL PROPHYLACTIC MASTECTOMY; MUTATION CARRIERS; SALPINGO-OOPHORECTOMY; RISK; SURGERY; WOMEN; PREDISPOSITION; PREVENTION; MANAGEMENT; EFFICACY;

D O I：

10.1093/annonc/mdr373

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：vi31 / vi34

页数：4

共 27 条

[1] Pregnancies, breast-feeding, and breast cancer risk in the international BRCA1/2 carrier cohort study (IBCCS) [J].

Andrieu, Nadine ;

Goldgar, David E. ;

Easton, Douglas F. ;

Rookus, Matti ;

Brohet, Richard ;

Antoniou, Antonis C. ;

Peock, Susan ;

Evans, Gareth ;

Eccles, Diana ;

Douglas, Fiona ;

Nogues, Catherine ;

Gauthier-Villars, Marion ;

Chompret, Agnes ;

van Leeuwen, Flora E. ;

Kluijt, Irina ;

Benitez, Javier ;

Arver, Brita ;

Olah, Edith ;

Chang-Claude, Jenny .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (08) :535-544

[2] Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].

Antoniou, A ;

Pharoah, PDP ;

Narod, S ;

Risch, HA ;

Eyfjord, JE ;

Hopper, JL ;

Loman, N ;

Olsson, H ;

Johannsson, O ;

Borg, Å ;

Pasini, B ;

Radice, P ;

Manoukian, S ;

Eccles, DM ;

Tang, N ;

Olah, E ;

Anton-Culver, H ;

Warner, E ;

Lubinski, J ;

Gronwald, J ;

Gorski, B ;

Tulinius, H ;

Thorlacius, S ;

Eerola, H ;

Nevanlinna, H ;

Syrjäkoski, K ;

Kallioniemi, OP ;

Thompson, D ;

Evans, C ;

Peto, J ;

Lalloo, F ;

Evans, DG ;

Easton, DF .

AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130

[3] Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial [J].

Audeh, M. William ;

Carmichael, James ;

Penson, Richard T. ;

Friedlander, Michael ;

Powell, Bethan ;

Bell-McGuinn, Katherine M. ;

Scott, Clare ;

Weitzel, Jeffrey N. ;

Oaknin, Ana ;

Loman, Niklas ;

Lu, Karen ;

Schmutzler, Rita K. ;

Matulonis, Ursula ;

Wickens, Mark ;

Tutt, Andrew .

LANCET, 2010, 376 (9737) :245-251

[4] Selective use of sentinel lymph node surgery during prophylactic mastectomy [J].

Boughey, Judy C. ;

Khakpour, Nazanin ;

Meric-Bernstam, Funda ;

Ross, Merrick I. ;

Kuerer, Henry M. ;

Singletary, Sonja E. ;

Babiera, Gildy V. ;

Arun, Banu ;

Hunt, Kelly K. ;

Bedrosian, Isabelle .

CANCER, 2006, 107 (07) :1440-1447

[5] Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy [J].

Byrski, Tomasz ;

Gronwald, Jacek ;

Huzarski, Tomasz ;

Grzybowska, Ewa ;

Budryk, Magdalena ;

Stawicka, Malgorzata ;

Mierzwa, Tomasz ;

Szwiec, Marek ;

Wisniowski, Rafal ;

Siolek, Monika ;

Dent, Rebecca ;

Lubinski, Jan ;

Narod, Steven .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) :375-379

[6] Clinical management of BRCA1 and BRCA2 mutation carriers [J].

Domchek, S. M. ;

Weber, B. L. .

ONCOGENE, 2006, 25 (43) :5825-5831

[7] Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers:: a prospective cohort study [J].

Domchek, SM ;

Friebel, TM ;

Neuhausen, SL ;

Wagner, T ;

Evans, G ;

Isaacs, C ;

Garber, JE ;

Daly, M ;

Eeles, R ;

Matloff, E ;

Tomlinson, GE ;

Van't Veer, L ;

Lynch, HT ;

Olopade, O ;

Weber, BL ;

Rebbeck, TR .

LANCET ONCOLOGY, 2006, 7 (03) :223-229

[8] Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality [J].

Domchek, Susan M. ;

Friebel, Tara M. ;

Singer, Christian F. ;

Evans, D. Gareth ;

Lynch, Henry T. ;

Isaacs, Claudine ;

Garber, Judy E. ;

Neuhausen, Susan L. ;

Matloff, Ellen ;

Eeles, Rosalind ;

Pichert, Gabriella ;

Van T'veer, Laura ;

Tung, Nadine ;

Weitzel, Jeffrey N. ;

Couch, Fergus J. ;

Rubinstein, Wendy S. ;

Ganz, Patricia A. ;

Daly, Mary B. ;

Olopade, Olufunmilayo I. ;

Tomlinson, Gail ;

Schildkraut, Joellen ;

Blum, Joanne L. ;

Rebbeck, Timothy R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (09) :967-975

[9] The Potential of PARP Inhibitors in Genetic Breast and Ovarian Cancers [J].

Drew, Yvette ;

Calvert, Hilary .

RECENT ADVANCES IN CLINICAL ONCOLOGY, 2008, 1138 :136-145

[10] Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations [J].

Fackenthal, James D. ;

Olopade, Olufunmilayo I. .

NATURE REVIEWS CANCER, 2007, 7 (12) :937-948

← 1 2 3 →